Stout T J, Sage C R, Stroud R M
Department of Biochemistry, School of Medicine, University of California, San Francisco 94143-0448, USA.
Structure. 1998 Jul 15;6(7):839-48. doi: 10.1016/S0969-2126(98)00086-0.
Enzymes have evolved to recognise their target substrates with exquisite selectivity and specificity. Whether fragments of the substrate--perhaps never available to the evolving enzyme--are bound in the same manner as the parent substrate addresses the fundamental basis of specificity. An understanding of the relative contributions of individual portions of ligand molecules to the enzyme-binding interaction may offer considerable insight into the principles of substrate recognition.
We report 12 crystal structures of Escherichia coli thymidylate synthase in complexes with available fragments of the substrate (dUMP), both with and without the presence of a cofactor analogue. The structures display considerable fidelity of binding mode and interactions. These complexes reveal several interesting features: the cofactor analogue enhances the localisation of substrate and substrate fragments near the reactive thiol; the ribose moiety reduces local disorder through additional specific enzyme-ligand interactions; the pyrimidine has multiple roles, ranging from stereospecificity to mechanistic competence; and the glycosidic linkage has an important role in the formation of a covalent attachment between substrate and enzyme.
The requirements of ligand-protein binding can be understood in terms of the binding of separate fragments of the ligand. Fragments which are subsystems of the natural substrate for the enzyme confer specific contributions to the binding affinity, orientation or electrostatics of the enzymatic mechanism. This ligand-binding analysis provides a complementary method to the more prevalent approaches utilising site-directed mutagenesis. In addition, these observations suggest a modular approach for rational drug design utilising chemical fragments.
酶已经进化到能够以极高的选择性和特异性识别其靶底物。底物的片段——也许进化中的酶从未接触过——是否以与母体底物相同的方式结合,这涉及特异性的基本基础。了解配体分子各个部分对酶结合相互作用的相对贡献,可能会为底物识别原理提供相当多的见解。
我们报道了大肠杆菌胸苷酸合酶与底物(dUMP)的可用片段形成的复合物的12种晶体结构,其中有无辅因子类似物。这些结构在结合模式和相互作用方面显示出相当高的保真度。这些复合物揭示了几个有趣的特征:辅因子类似物增强了底物和底物片段在反应性硫醇附近的定位;核糖部分通过额外的特异性酶-配体相互作用减少了局部无序;嘧啶有多种作用,从立体特异性到机制活性;糖苷键在底物与酶之间形成共价连接中起重要作用。
配体-蛋白质结合的要求可以通过配体单独片段的结合来理解。作为酶天然底物子系统的片段对酶促机制的结合亲和力、取向或静电作用有特定贡献。这种配体结合分析为利用定点诱变的更普遍方法提供了一种补充方法。此外,这些观察结果为利用化学片段进行合理药物设计提出了一种模块化方法。